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Abstract
Background: Gastrointestinal symptoms are common in patients with Chronic Fatigue Syndrome
(CFS). The objective of this study was to determine the frequency of these symptoms and explore
their relationship with objective (radionuclide) studies of upper GI function.
Methods: Thirty-two (32) patients with CFS and 45 control subjects completed a questionnaire
on upper GI symptoms, and the 32 patients underwent oesophageal clearance, and simultaneous
liquid and solid gastric emptying studies using radionuclide techniques compared with historical
controls.
Results: The questionnaires showed a significant difference in gastric (p > 0.01) symptoms and
swallowing difficulty. Nocturnal diarrhoea was a significant symptom not previously reported.
5/32 CFS subjects showed slightly delayed oesophageal clearance, but overall there was no
significant difference from the control subjects, nor correlation of oesophageal clearance with
symptoms. 23/32 patients showed a delay in liquid gastric emptying, and 12/32 a delay in solid
gastric emptying with the delay significantly correlated with the mean symptom score (for each p
0.001).
Conclusions:  GI symptoms in patients with chronic fatigue syndrome are associated with
objective changes of upper GI motility.
Background
Chronic Fatigue Syndrome (CFS) is a descriptive term
used to define a classifiable pattern of symptoms that can-
not be attributed to any alternative condition [1]. It can be
associated with immunological alterations, neuro-endo-
crine changes [2], sleep disturbance and disturbed neuro-
cognitive performance with abnormal cerebral perfusion
[3], but the pathophysiological significance of these is
uncertain. Skeletal neuromuscular function is usually nor-
mal in CFS sufferers [4].
Many with CFS have gastro-intestinal (GI) symptoms,
which are often unrecognised as being part of CFS. The
commonest of the upper GI symptoms include fullness
and bloating after a small meal, abdominal distension,
nausea, and loss of appetite. Lower GI tract symptoms
have considerable overlap with irritable bowel syndrome
[5].
The hypothesis explored in this paper is that symptoms of
possible upper gastrointestinal origin are more common
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in patients with CFS and are related to upper gastrointes-
tinal motility as assessed by radionuclide methods.
Methods
Subjects
Consecutive patients with CFS who met the Fukuda crite-
ria [6] for CFS were all seen by a single physician (RB).
Patients with any medical condition which could account
for chronic fatigue, a BMI > 30, previous GI surgery or
medication affecting the rate of gastric emptying were
excluded. Overt psychiatric disease was excluded at the
interview. The patients were asked to self assess their per-
centage reduction in activity from prior to the onset of
CFS as a marker of severity. Gastro-Intestinal symptoms
were evaluated in patients and controls by a standard
questionnaire prior to the gastric emptying studies [7].
Symptoms were divided into "oesophageal" (dysphagia,
heart burn, acid regurgitation), "gastric": (anorexia, nau-
sea, early satiety, bloating, abdominal distension, inter-
mittent abdominal pain), "other" frequency of bowel
actions, consistency of stools, presence or absence of diar-
rhoea, urgency and timing.
Symptoms were scored. 0, none, 1, mild (symptom could
be ignored), 2, moderate (symptom could not be ignored,
but did not influence daily activities), 3, severe, (symptom
influenced daily activities). A mean symptom score (max-
imum score 3) for the 6 gastric symptoms, and 3 oesopha-
geal symptoms was obtained.
The volunteer control subjects who completed the ques-
tionnaire were in regular full time employment, with no
history of excessive fatigue, on no GI medication, and had
no previous GI surgery.
Radionuclide measurement of upper GI motility
Details and normal ranges of this double isotope test have
been previously published [8]. The solid meal consisted of
100 g of cooked ground beef containing 40MBq in-vivo
labelled 99mTc-sulfur colloid-chicken liver, and the liquid
meal consisted of 150 ml of 10% dextrose in water con-
taining with 20 MBq of 67Ga-ethylenediaminetetraacetic
acid (EDTA). All medication (except oral contraceptives)
was discontinued for 24 hours prior to each study. The test
was performed at 10 am (after an overnight fast) and
monitored for at least two hours with the subject in the
sitting position with the scintillation camera behind. The
study commenced with a standardised oesophageal clear-
ance study (solid bolus) followed by eating the solid meal
and then immediately drinking the glucose solution. Each
study was continued for at least 2 hours. Oesophageal
clearance was expressed as time to 95% clearance (ref
range < 93 sec) [9], Liquid gastric emptying as half-clear-
ance time (ref 4–31 minutes) and solid emptying as
amount remaining at 100 min (ref 4–61%).
The GI questionnaires were compared between CFS and
control by Chi2, and Gastric emptying indices compared
with historical normal range (t test comparison of
means), and correlated with the mean symptom score (±
SD).
Table 1: Characteristics of CFS subjects vs controls. (SD)
CFS CONTROLS
Number 32 45
Sex F 22, M10 F 37, M 8
Age (yr) 38.5 ± 13.9 34.4 ± 8.5
Weight Kg 68.1 ± 12.1 71.8 ± 11.6
Duration CFS (yr) 9.5 ± 6.8
Severity, % reduction activity 65
Smoke % 18 17.8
Table 2: Percentage frequency of any gastrointestinal 
symptoms.
CFS % 
(n = 32)
CONTROLS % 
(n = 45)
GASTRIC
Abdominal discomfort 39 22.
Fullness after small meal 70 31*
Nausea 67 15*
Abdominal pain 76 27*
Loss of appetite 42 12*
Vomiting 22 2*
OESOPHAGEAL
Acid regurgitation 30 28
Heart burn 48 27
Swallowing difficulty 45 9*
OTHER
Bowel movements/ day (mean) 1.6 1.2
Constipation % 26 30
Consistency Formed % 67 80
Loose/Watery % 33 20
Nocturnal diarrhoea % 21 0*
Faecal Urgency % 51 16*
* indicates symptoms more frequent in CFS group p <.05, Chi2BMC Gastroenterology 2004, 4:32 http://www.biomedcentral.com/1471-230X/4/32
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The Study was approved by The Human Research Ethics
Committee of the Royal Adelaide Hospital and informed
consent given by the subjects.
Results
Thirty-two (32) CFS patients (22F), with a mean age of
38.5 years had gastric emptying studies. Forty-five (45)
control subjects undertook the questionnaire. The demo-
graphic details of the controls vs. patients are shown in
table 1 Gastro-intestinal symptoms were more common
in the CFS group (mean symptom score {MSS] 1.01 ±
0.87) than controls (MSS 0.24 ± 0.34) (table 2).
The overall, grouped gastric emptying studies of CFS sub-
jects showed no significant slowing of oesophageal clear-
ance p = 0.45 from the control population, and no
significant correlation between emptying and
oesophageal symptom score (r = 0.15) although 5 of the
symptomatic and 2 of the asymptomatic subjects 7/32
(22%), were slower than the 95% confidence limits, (fig
1), this did not reach statistical significance. The major
abnormality shown is a delay in the emptying of the liq-
uid phase in 23/32 72% of the patients, whereas 12/32
(38%) of solid emptying was delayed compared with the
historic controls (t comparison of means, figs 2 and 3,
group p  0.005). When the gastric emptying results were
compared to the mean symptom score there was a highly
significant correlation of solid (r = 0.81) and liquid (r =
0.65) delay which increased with the symptom score (p
0.001).
Discussion
G-I symptoms are common in patients with CFS. Abdom-
inal pain is distressing [10], often requiring analgesia for
relief. A previously unrecorded symptom in CFS patients
is nocturnal diarrhoea, which disrupts an already dis-
turbed sleep pattern. The most common upper GI
Oesophageal clearance time compared with oesophageal  symptoms in Chronic Fatigue Syndrome Figure 1
Oesophageal clearance time compared with oesophageal 
symptoms in Chronic Fatigue Syndrome. (Shaded area repre-
sents 95% confidence limit of normal reference range)
Per-cent gastric retention of solid food compared with mean  symptom score in chronic fatigue syndrome Figure 2
Per-cent gastric retention of solid food compared with mean 
symptom score in chronic fatigue syndrome. (Shaded area 
represents 95% confidence limit of normal reference range)
Time to 50% gastric emptying of liquid compared with mean  symptom score in chronic fatigue syndrome Figure 3
Time to 50% gastric emptying of liquid compared with mean 
symptom score in chronic fatigue syndrome. (Shaded area 
represents 95% confidence limit of normal reference range)BMC Gastroenterology 2004, 4:32 http://www.biomedcentral.com/1471-230X/4/32
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symptom is fullness and bloating after a small meal. The
usual medical explanation for the gut symptoms is 'irrita-
ble bowel'. Unless specific G-I questions are put to the CFS
patient they will not spontaneously discuss these
symptoms.
An abnormality in solid or liquid emptying or combina-
tions of these study parameters was more common in the
more symptomatic patients, and liquid was more fre-
quently affected. This is the opposite of the abnormality
seen in diabetic subjects [8], where the major abnormal-
ity, delay in the solid phase of gastric emptying has been
ascribed to autonomic dysfunction or hyperglycaemia. A
group of elderly subjects with a number of neurological
defects showed a delay in the liquid rather than the solid
emptying [11].
Symptoms and delayed gastric emptying in diabetic gas-
troparesis studies have not correlated well. In this study
there is a good correlation with symptoms. The common-
est of these was early satiety, fullness and bloating after
eating. There was though a poor correlation with
oesophageal symptoms and a disorder of oesophageal
emptying.
GI motility is complex, with central, local neuromuscular
and humoral influences. Non-specific endocrine
disturbances have been demonstrated in CFS, but the rel-
evance of these is unknown with regard to GI distur-
bances. Skeletal muscle fatigue appears to be of central
rather than peripheral origin, but again it is not known
whether this may be extrapolated to visceral muscle.
Inconclusive central changes have been documented. The
impact of disturbed sensory function is unknown, and
this could also involve peripheral nerves or the central
processing of sensory information.
Diagnostically, there is overlap between CFS, functional
dyspepsia and fibromyalgia and all may be related to
abnormal sensory processing [10,12,13]. Altered gastric
emptying has been shown in association with irritable
bowel syndrome [14].
Conclusions
These observations indicate that there is measurable dis-
turbance in upper gut motility corresponding with symp-
toms in CFS. Although the cause for these findings is not
apparent in this study, the more prominent delay in liquid
rather than solid emptying may point to a central rather
than a peripheral aetiology. The gastro-intestinal tract and
function should be properly investigated and the symp-
toms not necessarily be ascribed to irritable bowel
syndrome.
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